Tech Company Financing Transactions

Canton Biologics Funding Round

Canton Biologics closed a $300 million Series C funding round on 9/18/2023. Investors included Guangdong Technology Financial Group, SDIC Venture Capital and Taipu Life Science Investment.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Chuangzhihui Industrial Park, No. 19, Nanxiang 3rd Road Huan
Guangzhou, Guangdong, 510663
CN

Phone

Undisclosed

Website

www.cantonbio.com/en/index.aspx

Email Address

[email protected]

Overview

Canton Biologics is the biggest Contract Development Manufacture Organization in the South China, providing the one-stop integrated solutions that meet international regulatory standards and cover early discovery to commercialization for global innovative pharmaceutical enterprises.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Xiao Shen

        

Browse more venture capital transactions:

Prev: 9/18/2023: Bevz venture capital transaction
Next: 9/18/2023: Mojave venture capital transaction

Share this article

About Our VC Transactions Data

We report on funding rounds that are announced publicly. All VC database entries on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary